These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25009818)

  • 1. Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.
    Matar KM; Tayem YI
    Biomed Res Int; 2014; 2014():570910. PubMed ID: 25009818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered pharmacokinetics of enrofloxacin in experimental models of hepatic and renal impairment.
    Hwang YH; Kim MS; Song IB; Lim JH; Park BK; Yun HI
    Vet Res Commun; 2009 Jun; 33(5):481-7. PubMed ID: 19085067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic failure leads to lethality of chlordecone-amplified hepatotoxicity of carbon tetrachloride.
    Soni MG; Mehendale HM
    Fundam Appl Toxicol; 1993 Nov; 21(4):442-50. PubMed ID: 7504640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure.
    Jiko M; Yano I; Okuda M; Inui K
    Pharm Res; 2005 Feb; 22(2):228-34. PubMed ID: 15783070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald DL
    Epilepsy Res; 2014 Jul; 108(5):891-901. PubMed ID: 24725807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug.
    Doose DR; Walker SA; Gisclon LG; Nayak RK
    J Clin Pharmacol; 1996 Oct; 36(10):884-91. PubMed ID: 8930774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS; Burm JP
    Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pregnancy on topiramate pharmacokinetics in rabbits.
    Matar KM; Marafie NA
    Xenobiotica; 2011 May; 41(5):416-21. PubMed ID: 21271806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model.
    Zhu M; Yeung RY; Lin KF; Li RC
    Planta Med; 2000 Aug; 66(6):521-5. PubMed ID: 10985077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Mentha piperita L. leaf essential oil against CCl
    Bellassoued K; Ben Hsouna A; Athmouni K; van Pelt J; Makni Ayadi F; Rebai T; Elfeki A
    Lipids Health Dis; 2018 Jan; 17(1):9. PubMed ID: 29316974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of paclitaxel in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS
    Arch Pharm Res; 2002 Dec; 25(6):973-7. PubMed ID: 12510856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of ciprofloxacin into the central nervous system in rats with acute renal or hepatic failure.
    Naora K; Ichikawa N; Hirano H; Iwamoto K
    J Pharm Pharmacol; 1999 May; 51(5):609-16. PubMed ID: 10411221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
    Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
    Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of laparotomy on disposition kinetics of diclofenac in CCl4-intoxicated rats.
    Fukuyama T; Yamaoka K; Tabata K; Nakagawa T
    Biol Pharm Bull; 1995 Feb; 18(2):251-5. PubMed ID: 7742793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients.
    Doose DR; Brodie MJ; Wilson EA; Chadwick D; Oxbury J; Berry DJ; Schwabe S; Bialer M
    Epilepsia; 2003 Jul; 44(7):917-22. PubMed ID: 12823574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pharmacokinetics of daunorubicin in rats with CCl4-induced hepatic injury.
    Choi MK; Song IS; Kim DD; Chung SJ; Shim CK
    J Pharm Pharm Sci; 2007; 10(4):443-54. PubMed ID: 18261366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional impairment of sinusoidal membrane transport of organic cations in rats with CCl4-induced hepatic failure.
    Hong SS; Chung SJ; Shim CK
    Pharm Res; 2000 Jul; 17(7):833-8. PubMed ID: 10990202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
    Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.